Organon & Statistics
Share Statistics
Organon & has 259.96M
shares outstanding. The number of shares has increased by 0.3%
in one year.
| Shares Outstanding | 259.96M |
| Shares Change (YoY) | 0.3% |
| Shares Change (QoQ) | 0.16% |
| Owned by Institutions (%) | 80.07% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 302 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 19.7M, so 7.65% of the outstanding
shares have been sold short.
| Short Interest | 19.7M |
| Short % of Shares Out | 7.65% |
| Short % of Float | 10.21% |
| Short Ratio (days to cover) | 4.39 |
Valuation Ratios
The PE ratio is 4.44 and the forward
PE ratio is 2.24.
Organon &'s PEG ratio is
-0.27.
| PE Ratio | 4.44 |
| Forward PE | 2.24 |
| PS Ratio | 0.6 |
| Forward PS | 0.4 |
| PB Ratio | 8.13 |
| P/FCF Ratio | 5.02 |
| PEG Ratio | -0.27 |
Financial Ratio HistoryEnterprise Valuation
Organon & has an Enterprise Value (EV) of 12.04B.
| EV / Sales | 1.88 |
| EV / EBITDA | 7.46 |
| EV / EBIT | 12.82 |
| EV / FCF | 15.76 |
Financial Position
The company has a current ratio of 1.6,
with a Debt / Equity ratio of 18.81.
| Current Ratio | 1.6 |
| Quick Ratio | 1.11 |
| Debt / Equity | 18.81 |
| Debt / EBITDA | 5.51 |
| Debt / FCF | 11.62 |
| Interest Coverage | 2.86 |
Financial Efficiency
Return on Equity is 183.05% and Return on Invested Capital is 15.29%.
| Return on Equity | 183.05% |
| Return on Assets | 6.59% |
| Return on Invested Capital | 15.29% |
| Revenue Per Employee | $640,300 |
| Profits Per Employee | $86,400 |
| Employee Count | 10,000 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 2.03 |
Taxes
| Income Tax | -57M |
| Effective Tax Rate | -7.06% |
Stock Price Statistics
The stock price has increased by -55.52% in the
last 52 weeks. The beta is 0.7, so Organon &'s
price volatility has been higher than the market average.
| Beta | 0.7 |
| 52-Week Price Change | -55.52% |
| 50-Day Moving Average | 11.52 |
| 200-Day Moving Average | 15.67 |
| Relative Strength Index (RSI) | 43.28 |
| Average Volume (20 Days) | 5,764,256 |
Income Statement
In the last 12 months, Organon & had revenue of 6.4B
and earned 864M
in profits. Earnings per share was 3.36.
| Revenue | 6.4B |
| Gross Profit | 3.71B |
| Operating Income | 1.49B |
| Net Income | 864M |
| EBITDA | 1.61B |
| EBIT | 1.33B |
| Earnings Per Share (EPS) | 3.36 |
Full Income StatementBalance Sheet
The company has 675M in cash and 8.88B in
debt, giving a net cash position of -8.21B.
| Cash & Cash Equivalents | 675M |
| Total Debt | 8.88B |
| Net Cash | -8.21B |
| Retained Earnings | 1.01B |
| Total Assets | 13.16B |
| Working Capital | 1.76B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 939M
and capital expenditures -175M, giving a free cash flow of 764M.
| Operating Cash Flow | 939M |
| Capital Expenditures | -175M |
| Free Cash Flow | 764M |
| FCF Per Share | 2.97 |
Full Cash Flow StatementMargins
Gross margin is 58.02%, with operating and profit margins of 23.21% and 13.49%.
| Gross Margin | 58.02% |
| Operating Margin | 23.21% |
| Pretax Margin | 12.6% |
| Profit Margin | 13.49% |
| EBITDA Margin | 25.19% |
| EBIT Margin | 23.21% |
| FCF Margin | 11.93% |
